Takayuki Miki

5.3k total citations · 1 hit paper
121 papers, 4.4k citations indexed

About

Takayuki Miki is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Takayuki Miki has authored 121 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pathology and Forensic Medicine, 44 papers in Cardiology and Cardiovascular Medicine and 34 papers in Molecular Biology. Recurrent topics in Takayuki Miki's work include Cardiac Ischemia and Reperfusion (57 papers), Cardiac Arrest and Resuscitation (22 papers) and Cardiovascular Function and Risk Factors (21 papers). Takayuki Miki is often cited by papers focused on Cardiac Ischemia and Reperfusion (57 papers), Cardiac Arrest and Resuscitation (22 papers) and Cardiovascular Function and Risk Factors (21 papers). Takayuki Miki collaborates with scholars based in Japan, United States and Norway. Takayuki Miki's co-authors include Tetsuji Miura, Masaya Tanno, Kazuaki Shimamoto, Toshiyuki Yano, Hidemichi Kouzu, Atsushi Kuno, Michael V. Cohen, Satoshi Yuda, James M. Downey and Akihito Tsuchida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Takayuki Miki

117 papers receiving 4.3k citations

Hit Papers

Diabetic cardiomyopathy: pathophysiology and clinical fea... 2012 2026 2016 2021 2012 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diabetic cardiomyopathy: pathophysiology and clinical features
    2012 380 citations Takayuki Miki, Hidemichi Kouzu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takayuki Miki Japan 39 1.8k 1.6k 1.5k 904 613 121 4.4k
Aleksandar Jovanović United Kingdom 31 1.5k 0.8× 1.4k 0.9× 958 0.6× 658 0.7× 448 0.7× 133 3.4k
Sharon L. Hale United States 34 1.4k 0.7× 996 0.6× 1.4k 0.9× 796 0.9× 925 1.5× 101 3.8k
Nina C. Weber Netherlands 35 1.2k 0.7× 1.1k 0.7× 963 0.6× 661 0.7× 985 1.6× 126 4.0k
Zequan Yang United States 36 1.1k 0.6× 1.1k 0.7× 1.6k 1.1× 395 0.4× 893 1.5× 87 4.6k
Guro Valen Sweden 35 1.2k 0.7× 1.7k 1.0× 1.0k 0.7× 513 0.6× 672 1.1× 133 4.0k
Masaya Tanno Japan 36 1.2k 0.6× 2.2k 1.4× 949 0.6× 344 0.4× 465 0.8× 122 4.6k
Eliana Lucchinetti Switzerland 33 1.4k 0.7× 925 0.6× 926 0.6× 722 0.8× 709 1.2× 78 3.6k
Jo El J. Schultz United States 26 1.3k 0.7× 1.6k 1.0× 1.3k 0.9× 740 0.8× 433 0.7× 46 3.4k
Zhi‐Qing Zhao United States 35 3.3k 1.8× 1.1k 0.7× 1.2k 0.8× 1.9k 2.1× 755 1.2× 95 5.0k
Hitoshi Takano Japan 30 2.3k 1.2× 848 0.5× 1.2k 0.8× 1.1k 1.2× 637 1.0× 127 4.0k

Countries citing papers authored by Takayuki Miki

Since Specialization
Citations

This map shows the geographic impact of Takayuki Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayuki Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayuki Miki more than expected).

Fields of papers citing papers by Takayuki Miki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayuki Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayuki Miki. The network helps show where Takayuki Miki may publish in the future.

Co-authorship network of co-authors of Takayuki Miki

This figure shows the co-authorship network connecting the top 25 collaborators of Takayuki Miki. A scholar is included among the top collaborators of Takayuki Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayuki Miki. Takayuki Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Hiroyuki, et al.. (2024). Visualization of the scleral structure changes at various stages of eyes with myopic maculopathy using polarization-sensitive OCT. Asia-Pacific Journal of Ophthalmology. 13(6). 100117–100117. 1 indexed citations
2.
Kouzu, Hidemichi, Tatsuya Sato, Atsushi Kuno, et al.. (2023). Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts. Physiological Reports. 11(4). e15608–e15608. 11 indexed citations
3.
Shibata, Satoru, Norihito Moniwa, Atsushi Kuno, et al.. (2021). Involvement of necroptosis in contrast-induced nephropathy in a rat CKD model. Clinical and Experimental Nephrology. 25(7). 708–717. 3 indexed citations
4.
Sato, Tatsuya, Takayuki Miki, Shinya Furukawa, et al.. (2019). Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes. Journal of Diabetes Investigation. 10(6). 1593–1594. 3 indexed citations
5.
Nakata, Kei, Takayuki Miki, Masaya Tanno, et al.. (2016). Abstract 17519: Distinct Impacts of Sleep-disordered Breathing on Glycemic Variability in Patients With and Without Heart Failure. Circulation. 1 indexed citations
6.
Miki, Takayuki, Tatsuya Sato, Masaya Tanno, et al.. (2014). Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?. Cardiovascular Diabetology. 13(1). 20 indexed citations
7.
Itoh, Takahito, Hidemichi Kouzu, Takayuki Miki, et al.. (2012). Cytoprotective regulation of the mitochondrial permeability transition pore is impaired in type 2 diabetic Goto–Kakizaki rat hearts. Journal of Molecular and Cellular Cardiology. 53(6). 870–879. 19 indexed citations
8.
Miki, Takayuki, Takahito Itoh, Daisuke Sunaga, & Tetsuji Miura. (2012). Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovascular Diabetology. 11(1). 67–67. 129 indexed citations
9.
Miura, Tetsuji & Takayuki Miki. (2009). GSK-3.BETA., a Therapeutic Target for Cardiomyocyte Protection. Circulation Journal. 73(7). 1184–1192. 119 indexed citations
10.
Miura, Tetsuji, Masahiro Nishihara, & Takayuki Miki. (2009). Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Role of GSK-3β in Myocardial Protection Against Ischemia/Reperfusion Injury. Journal of Pharmacological Sciences. 109(2). 162–167. 39 indexed citations
11.
Miura, Tetsuji, Toshiyuki Yano, Kazuyuki Naitoh, et al.. (2007). δ-Opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-ε-mediated phosphorylation of connexin 43. American Journal of Physiology-Heart and Circulatory Physiology. 293(3). H1425–H1431. 35 indexed citations
12.
Nishihara, Masahiro, Tetsuji Miura, Takayuki Miki, et al.. (2007). Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection. Journal of Molecular and Cellular Cardiology. 43(5). 564–570. 194 indexed citations
13.
Yano, Toshiyuki, Tetsuji Miura, Peter Whittaker, et al.. (2006). Macrophage Colony-Stimulating Factor Treatment After Myocardial Infarction Attenuates Left Ventricular Dysfunction by Accelerating Infarct Repair. Journal of the American College of Cardiology. 47(3). 626–634. 62 indexed citations
14.
Baxter, Gary F., S L Hale, Takayuki Miki, et al.. (2000). Adenosine A1 Agonist at Reperfusion Trial (AART): Results of a Three-Center, Blinded, Randomized, Controlled Experimental Infarct Study. Cardiovascular Drugs and Therapy. 14(6). 607–614. 51 indexed citations
15.
Kokado, Y, Masahiro Kyo, S. Takahara, et al.. (1998). Correlation between banff classification and reversal of acute renal rejection. Transplantation Proceedings. 30(7). 3064–3066. 4 indexed citations
16.
Suzuki, Katsuo, Tetsuji Miura, Takayuki Miki, Akihito Tsuchida, & Kazuaki Shimamoto. (1998). Infarct-Size Limitation by Preconditioning is Enhanced by Dipyridamole Administered Before But Not After Preconditioning: Evidence for the Role of Interstitial Adenosine Level During Preconditioning as a Primary Determinant of Cardioprotection. Journal of Cardiovascular Pharmacology. 31(1). 1–9. 22 indexed citations
17.
Kokado, Y, S. Takahara, Masahiro Kyo, et al.. (1998). Low-dose tacrolimus (FK506)-based immunosuppressive protocol in living donor renal transplantation. Transplant International. 11(0). S60–S64. 11 indexed citations
18.
Miki, Takayuki, et al.. (1996). Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation. Journal of the American College of Cardiology. 28(6). 1616–1622. 43 indexed citations
19.
Miura, Tetsuji, Mahiko Goto, Takayuki Miki, et al.. (1995). Glibenclamide, a Blocker of ATP-Sensitive Potassium Channels, Abolishes Infarct Size Limitation by Preconditioning in Rabbits Anesthetized with Xylazine/Pentobarbital but Not with Pentobarbital Alone. Journal of Cardiovascular Pharmacology. 25(4). 531–538. 25 indexed citations
20.
Adachi, Takayoshi, et al.. (1990). [A case of constrictive pericarditis due to traumatic pericardial hematoma].. PubMed. 43(5). 393–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleksandar Jovanović Breakdown of academic impact, for papers by Sharon L. Hale Breakdown of academic impact, for papers by Nina C. Weber Breakdown of academic impact, for papers by Zequan Yang Breakdown of academic impact, for papers by Guro Valen Breakdown of academic impact, for papers by Masaya Tanno Breakdown of academic impact, for papers by Eliana Lucchinetti Breakdown of academic impact, for papers by Jo El J. Schultz Breakdown of academic impact, for papers by Zhi‐Qing Zhao Breakdown of academic impact, for papers by Hitoshi Takano
Rankless by CCL
2026